RESUMO
The past two years have been dominated by COVID-19, the treatment of this virus, vaccination, and complications due to infection. Not all effects of the virus have yet been described. We present a case report in which the patient suffered from Stevens-Johnson syndrome caused by COVID-19. The patient was treated with prednisolone and recovered within a few days. Since SARS-CoV-2 is a fairly new virus it is important to have knowledge about the different outcomes and distinguish these from outcomes caused by other reasons. This could in the long term improve the treatment.
Assuntos
COVID-19 , Síndrome de Stevens-Johnson , COVID-19/complicações , Humanos , Prednisolona/uso terapêutico , SARS-CoV-2 , Síndrome de Stevens-Johnson/complicações , Síndrome de Stevens-Johnson/diagnóstico , Síndrome de Stevens-Johnson/tratamento farmacológico , Vacinação/efeitos adversosRESUMO
Merkel cell carcinoma (MCC) is a subtype of nonmelanoma skin cancer (NMSC) with increasing incidence. Clinically, MCC resembles other far less-aggressive NMSCs, and the pathogenesis is still not understood completely. Rapid diagnosis and treatment are essential to improve overall survival. We present a case report of a 74-year-old female, who had noticed a rapidly growing, oozing tumor on her right flank. She was hesitant to contact the dermatology ward where she had regular checkups as she was afraid of contracting COVID-19. This was in the beginning of the COVID-19 pandemic. At presentation, she had a large exophytic MCC on her right flank and multiple metastases. The disease was at a late stage, and palliative care was the only treatment option left. With this case, we wish to report a rather uncharacteristic location and size of an MCC tumor and suggest that fear of the pandemic and the COVID-19 lockdown has impacted dramatically on attendance of symptomatic patients.
